Agilent Technologies (A)
(Delayed Data from NYSE)
$136.68 USD
-2.95 (-2.11%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $136.70 +0.02 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$136.68 USD
-2.95 (-2.11%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $136.70 +0.02 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Zacks News
Top Ranked Momentum Stocks to Buy for February 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 26th:
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
Top Ranked Momentum Stocks to Buy for February 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 25th:
Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent (A) Upgraded to Buy: Here's Why
by Zacks Equity Research
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
Agilent (A) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Agilent (A) reports strong fiscal first-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.11% and 1.02%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
by Zacks Equity Research
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
Will New Technologies Benefit Agilent (A) in Q1 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal first-quarter 2019 results.
3 Things to Know About Q4 Earnings Season
by Sheraz Mian
We continue to see the picture that emerged from the Q4 earnings season as not great, but it is not bad either.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TE Connectivity (TEL) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal first-quarter 2019 results are expected to benefit from robust solutions portfolio and normalizing seasonal trend in the end-markets.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
Waters' (WAT) strong segmental and end-market performance is likely to drive fourth-quarter 2018 results.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Agilent (A) to Expand Cell Analysis Offerings in Ireland
by Zacks Equity Research
Agilent (A) is set to expand the Cork facility in Ireland in a bid to expand its capabilities in the cell analysis space.
Agilent Technologies (A) in Focus: Stock Moves 7.8% Higher
by Zacks Equity Research
Agilent Technologies (A) shares rose almost 8% in the last trading session, amid huge volumes.
Agilent (A) Surpasses Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Agilent (A) reports strong fiscal fourth-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 10.96% and 3.05%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) Hikes Quarterly Dividend, Rewards Shareholders
by Zacks Equity Research
Agilent (A) hikes dividend to 16.4 cents per share in a bid to reward its shareholders.
Will New Technologies Benefit Agilent (A) in Q4 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal fourth-quarter 2018 results.
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Automotive Strength & Acquisitions Aid AVX Q2 Earnings?
by Zacks Equity Research
AVX's fiscal second-quarter results are likely to benefit from acquisitions and strength in the automotive market. However, weakness in the smartphone market might impact its results.
Agilent Technologies Enters Oversold Territory
by Zacks Equity Research
Agilent Technologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.